nav-left cat-right
cat-right

Playing God; Is Genetic Testing The Answer To A Mo...

Some parents don’t want to know the sex of their upcoming child. Others do. DNA profiling has been a hot topic amongst scientists for years and this week the topic heats up even more as a few reports published last December are now appearing on the scientific grid months later. Included in the studies is news that doctors could essentially reconstruct a baby’s genetic makeup by recovering fragments of fetal...

James Thomson’s Cellular Dynamics Launches i...

The University of Wisconsin’s James Thomson, whose vision was behind the founding of Cellular Dynamics, has from the initial creation of Induced Pluripotent Stem Cells felt that their use in the testing of new drugs would mark their greatest contribution, at least initially.Thursday the company announced the commercial launch of iCell Cardiomyocytes for use in testing of new drug candidates by the pharmaceutical...

Tepnel Expands Genetic Services Portfolio with Add...

MANCHESTER, United Kingdom & STAMFORD, Conn.–Tepnel Life Sciences PLC (AIM: TED) today announced that it has expanded its molecular genetic services offering through the addition of Illumina’s iScan System, a next-generation scanner that provides researchers conducting genetic variation studies with significantly greater throughput and application diversity. This announcement marks the first anniversary of...

BioServe Introduces Customizable DNA Panels for Ge...

BELTSVILLE, MD — September 11, 2008 — BioServe today announced a more affordable pricing plan for its vast bank of DNA with comprehensive, de-identified, covariate data that includes age, gender, diet, body mass index (BMI), and race. In addition, each sample has data on the complete diagnostic and treatment history of the donor. BioServe’s DNA represents a wide range of disease states including cancers...

Rentschler Biotechnologie Announces Cooperation wi...

Laupheim, Germany, Mai 21, 2008 – Rentschler Biotechnologie and Boehringer Ingelheim, both leading companies in biopharmaceutical development and production, have signed a preferred partnership agreement. The cooperation will enable Rentschler Biotechnologie’s clients to gain access to Boehringer Ingelheim’s large-scale mammalian biopharmaceutical production facilities in Biberach, Germany and vice ...

Seegene Multi-Pathogen Detection Tests Now Compati...

Rockville, MD, April 23, 2008: Seegene today announced that its Seeplex(R) multi-pathogen tests are now optimized for Lab 901’s ScreenTape(R)  and Caliper LifeSciences’ LC90(R)  automated detection systems. Compatibility with these two leading detection systems opens the way for Seeplex tests to be used throughout a wide spectrum of labs, from small to mid-sized labs to large commercial reference...
Page 10 of 11« First...7891011